Moleculin Releases Next CEO Corner Segment Highlighting Recent Progress in Annamycin MIRACLE Trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St treads water as chips rise, megacaps fall ahead of Fed, Big Tech earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 8.10 -1.17 (12.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.27 | 52 Week High | $9.58 | |||
| Open | $9.41 | 52 Week Low | $2.34 | |||
| Day High | $10.24 | P/E | N/A | |||
| Day Low | $8.10 | EPS | $-0.34 | |||
| Volume | 77,532 | |||||
